Requests that the FDA require updating the pregnancy safety warnings in the labels of serotonin reuptake inhibitors: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors.
🏛 Food and Drug Administration (FDA)FDA-2025-P-6094
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.